Effects of Posterior Gastropexy During Sleeve Gastrectomy on Quality of Life
GP-LSG
GP-LSG
Sponsor study identifier
interventional
50
1 country
1
Study Start
March 1, 2023
Actual (reported)Primary Completion
April 1, 2025
Actual (reported)Study Completion
April 1, 2025
Actual (reported)This randomized controlled trial evaluates the clinical outcomes and quality of life in patients undergoing laparoscopic sleeve gastrectomy with or without posterior gastropexy. The primary objective is to assess the effectiveness of posterior gastropexy in reducing postoperative reflux and improving overall patient satisfaction, with a 12-month follow-up period.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 1, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2023
Actual (reported)April 1, 2025
Actual (reported)April 1, 2025
Actual (reported)September 25, 2026
Actual (reported)October 6, 2026
Actual (reported)Gastrointestinal Quality of Life
Assessment of the GIQLI total score based on 36 items covering physical, emotional, and social functioning, along with gastrointestinal symptoms, scored from 0 to 144.
At 6 months and 1 year postoperatively
Body Mass Index
Measurement of the patient body mass index expressed in kilograms per meter squared (kg/m²).
At 6 months and 1 year postoperatively
Patients undergo laparoscopic sleeve gastrectomy combined with posterior gastropexy technique.
Patients undergo standard laparoscopic sleeve gastrectomy alone without posterior gastropexy.
Laparoscopic sleeve gastrectomy combined with posterior gastropexy to assess clinical outcomes and GERD reduction.
Standard laparoscopic sleeve gastrectomy procedure without posterior gastropexy.
Helwan University
Cairo, Cairo Governorate, 11828, Egypt
50 participants (actual enrollment reported by the registry).
First Submitted
September 25, 2026
First Posted
October 6, 2026
Study Start
March 1, 2023
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 1, 2025
Actual (reported)Study Completion
April 1, 2025
Actual (reported)Last Updated
October 6, 2026
Record last verified: 2026-10
Yes, anonymized individual participant data will be made available upon reasonable request to the corresponding author.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: